Published in Postgrad Med J on July 01, 2006
18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol (2011) 1.21
Fatal Subacute Hepatic Failure in a Patient with AA-Type Amyloidosis: Case Report. Patholog Res Int (2010) 0.83
Amyloidosis and subacute liver failure. Gastroenterol Hepatol (N Y) (2012) 0.75
Myeloma-associated systemic amyloidosis masquerading as NASH-associated cirrhosis and diabetic microvascular complications. Oxf Med Case Reports (2015) 0.75
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut (1998) 2.51
Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL) J Gastroenterol (1995) 2.01
Multiple myeloma. Lancet (2004) 2.00
Common bile duct obstruction caused by multiple myeloma of the pancreas. Gastrointest Endosc (1996) 1.07
Liver involvement in multiple myeloma. Am J Hematol (1985) 1.02
IgA multiple myeloma presenting as non-obstructive jaundice. Postgrad Med J (2004) 0.90
Hepatic failure due to myeloma-associated amyloidosis. J Gastroenterol (1998) 0.90
Light chain myeloma presenting as severe obstructive jaundice due to hepatic amyloidosis. Eur J Haematol (1999) 0.84
Extrahepatic biliary obstruction and liver failure secondary to myeloma of the pancreas. Hum Pathol (1982) 0.82
Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother (1999) 3.29
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation (1999) 2.95
Ferritin: design and formation of an iron-storage molecule. Philos Trans R Soc Lond B Biol Sci (1984) 2.94
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
The formation of ferritin from apoferritin. Kinetics and mechanism of iron uptake. Biochem J (1972) 2.86
Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther (2010) 2.77
Mineralization in ferritin: an efficient means of iron storage. J Struct Biol (1999) 2.69
Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med (1991) 2.65
Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution. J Mol Biol (1997) 2.49
Ferritin mutants of Escherichia coli are iron deficient and growth impaired, and fur mutants are iron deficient. J Bacteriol (1999) 2.37
Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol (1992) 2.31
Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther (2014) 2.28
The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality. Aliment Pharmacol Ther (2014) 2.10
Electron density map of apoferritin at 2.8-A resolution. Nature (1978) 2.03
Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding. Aliment Pharmacol Ther (2014) 1.98
Ferric oxyhydroxide core of ferritin. Nature (1967) 1.91
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
Management and outcome of pregnancy in autoimmune hepatitis. Gut (2001) 1.82
Identification of the ferroxidase centre in ferritin. FEBS Lett (1989) 1.78
The haemoglobin-like protein (HMP) of Escherichia coli has ferrisiderophore reductase activity and its C-terminal domain shares homology with ferredoxin NADP+ reductases. FEBS Lett (1992) 1.77
Structure, function, and evolution of ferritins. J Inorg Biochem (1992) 1.77
Crystal structure of manganese catalase from Lactobacillus plantarum. Structure (2001) 1.71
Cloning, sequencing, and mapping of the bacterioferritin gene (bfr) of Escherichia coli K-12. J Bacteriol (1989) 1.71
N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med (1997) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60
Electron-microscopic and chemical studies of oligomers in horse ferritin. Biochem J (1968) 1.60
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis. Clin Exp Dermatol (2006) 1.58
Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J (1992) 1.58
Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology (1996) 1.57
Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology (2000) 1.53
Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg (1989) 1.52
Microbes, peptic ulcer, and relapse rates with different drugs. Lancet (1984) 1.51
Mössbauer spectroscopic investigation of structure-function relations in ferritins. Biochim Biophys Acta (1991) 1.47
Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med (2001) 1.45
The effect of low molecular weight heparin on intimal hyperplasia in vein grafts. Eur J Vasc Surg (1994) 1.39
The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. Aust N Z J Med (1985) 1.38
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol (2010) 1.35
Defining the roles of the threefold channels in iron uptake, iron oxidation and iron-core formation in ferritin: a study aided by site-directed mutagenesis. Biochem J (1993) 1.35
The formation of ferritin from apoferritin. Catalytic action of apoferritin. Biochem J (1973) 1.34
The release of iron from horse spleen ferritin to 1,10-phenanthroline. Biochem J (1974) 1.33
Demonstration of cytokeratins and an epithelial membrane antigen in chordomas and human fetal notochord. Am J Surg Pathol (1985) 1.33
The binding of ferric iron by ferritin. Biochem J (1979) 1.32
Ferritin iron uptake and release. Structure-function relationships. Biochem J (1974) 1.31
Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. J Biol Chem (1992) 1.30
Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol (1991) 1.30
Iron (II) oxidation and early intermediates of iron-core formation in recombinant human H-chain ferritin. Biochem J (1993) 1.30
Site-directed replacement of the coaxial heme ligands of bacterioferritin generates heme-free variants. J Biol Chem (1995) 1.28
Structure and composition of ferritin cores from pea seed (Pisum sativum). Biochim Biophys Acta (1993) 1.27
Bacterioferritins and ferritins are distantly related in evolution. Conservation of ferroxidase-centre residues. FEBS Lett (1991) 1.27
Ferritin: molecular structure and iron-storage mechanisms. Prog Biophys Mol Biol (1980) 1.26
Detection of group B streptococcal antigen in necropsy specimens using monoclonal antibody and immunoperoxidase staining. J Clin Pathol (1986) 1.25
The Haglund syndrome: initial and differential diagnosis. Radiology (1982) 1.25
Influence of site-directed modifications on the formation of iron cores in ferritin. J Mol Biol (1991) 1.25
Recombinant H-chain ferritins: effects of changes in the 3-fold channels. FEBS Lett (1989) 1.24
Effect of ferritin-containing fractions with different iron loading on lipid peroxidation. Biochem J (1983) 1.22
The high-resolution X-ray crystallographic structure of the ferritin (EcFtnA) of Escherichia coli; comparison with human H ferritin (HuHF) and the structures of the Fe(3+) and Zn(2+) derivatives. J Mol Biol (2001) 1.22
On the structure of hemosiderin and its relationship to ferritin. J Ultrastruct Res (1971) 1.21
Ferritin: an iron-storage molecule. Semin Hematol (1977) 1.19
Kinetic and structural characterization of an intermediate in the biomineralization of bacterioferritin. FEBS Lett (1993) 1.19
Dinuclear center of ferritin: studies of iron binding and oxidation show differences in the two iron sites. Biochemistry (1997) 1.17
Iron(II) oxidation by H chain ferritin: evidence from site-directed mutagenesis that a transient blue species is formed at the dinuclear iron center. Biochemistry (1995) 1.15
Iron metabolism in transgenic mice with hypoplastic anaemia due to incomplete deficiency of erythropoietin. Br J Haematol (1997) 1.14
Identification of the ferroxidase centre of Escherichia coli bacterioferritin. Biochem J (1995) 1.14
Spectroscopic studies on the binding of iron, terbium, and zinc by apoferritin. J Inorg Biochem (1984) 1.13
Reconstituted and native iron-cores of bacterioferritin and ferritin. J Mol Biol (1987) 1.13
Lues maligna. Clin Exp Dermatol (2004) 1.11
Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol (1998) 1.11
Uptake and release of ferritin iron. Surface effects and exchange within the crystalline core. Biochem J (1974) 1.11
A molecular analysis of the 53.3 minute region of the Escherichia coli linkage map. J Gen Microbiol (1991) 1.11
Acute liver damage and ecstasy ingestion. Gut (1996) 1.11
The structural relationship between ferritin protein and its mineral core. J Mol Biol (1969) 1.10
Mössbauer spectroscopic study of the initial stages of iron-core formation in horse spleen apoferritin: evidence for both isolated Fe(III) atoms and oxo-bridged Fe(III) dimers as early intermediates. Biochemistry (1989) 1.09
Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J Pathol (1999) 1.09
Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol (2006) 1.09
Overproduction, purification and characterization of the Escherichia coli ferritin. Eur J Biochem (1993) 1.08
The Haglund painful heel syndrome. Experimental investigation of cause and therapeutic implications. Clin Orthop Relat Res (1984) 1.08
Letter: guidelines for the management of autoimmune hepatitis. Aliment Pharmacol Ther (2014) 1.07
How the presence of three iron binding sites affects the iron storage function of the ferritin (EcFtnA) of Escherichia coli. FEBS Lett (1998) 1.06
Molecular size and symmetry of the bacterioferritin of Escherichia coli. X-ray crystallographic characterization of four crystal forms. J Mol Biol (1989) 1.06
Bilateral adrenal lymphoma presenting as Addison's disease. Postgrad Med J (1989) 1.06
Amino-acid sequence and predicted three-dimensional structure of pea seed (Pisum sativum) ferritin. Biochem J (1992) 1.06
Mechanism of catalysis of Fe(II) oxidation by ferritin H chains. FEBS Lett (1992) 1.05
The formation of ferritin from apoferritin. Inhibition and metal ion-binding studies. Biochem J (1973) 1.05
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol (1999) 1.04
Direct observation of the iron binding sites in a ferritin. FEBS Lett (1994) 1.03
Incorporation and release of inorganic phosphate in horse spleen ferritin. Biochem J (1978) 1.03
Structure of horse-spleen apoferritin at 6 angstom resolution. Nature (1975) 1.02
Amino acid sequence of the bacterioferritin (cytochrome b1) of Escherichia coli-K12. Biochem Biophys Res Commun (1989) 1.02
Haem and non-haem iron sites in Escherichia coli bacterioferritin: spectroscopic and model building studies. Biochem J (1993) 1.01
Overproduction, purification and characterization of the bacterioferritin of Escherichia coli and a C-terminally extended variant. Eur J Biochem (1993) 1.01
Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol (2000) 1.00
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Histiocytic lymphoma: a report of a case with an unusual phenotype. J Pathol (1985) 0.99